A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced Apoptosis

Autor: Robert K. Winn, William Ricketts, C. Frank Bennett, Joan C. Tupper, John M. Harlan, Douglas D. Bannerman
Rok vydání: 2001
Předmět:
Lipopolysaccharides
Proteasome Endopeptidase Complex
Endothelium
Cell Survival
Lactacystin
CASP8 and FADD-Like Apoptosis Regulating Protein
Apoptosis
Cycloheximide
Biology
Biochemistry
chemistry.chemical_compound
Multienzyme Complexes
medicine
Humans
Molecular Biology
Cells
Cultured

DNA Primers
Inhibitor of apoptosis domain
Base Sequence
Tumor Necrosis Factor-alpha
Hydrolysis
Intracellular Signaling Peptides and Proteins
NF-kappa B
Cell Biology
Oligonucleotides
Antisense

Molecular biology
Neoplasm Proteins
Cell biology
Endothelial stem cell
Cysteine Endopeptidases
medicine.anatomical_structure
Proto-Oncogene Proteins c-bcl-2
chemistry
Proteasome
Proteasome inhibitor
Myeloid Cell Leukemia Sequence 1 Protein
Tumor necrosis factor alpha
Endothelium
Vascular

Carrier Proteins
Interleukin-1
medicine.drug
Zdroj: Journal of Biological Chemistry. 276:14924-14932
ISSN: 0021-9258
DOI: 10.1074/jbc.m100819200
Popis: Lipopolysaccharide (LPS) has been implicated as the bacterial component responsible for much of the endothelial cell injury/dysfunction associated with Gram-negative bacterial infections. Protein synthesis inhibition is required to sensitize the endothelium to lipopolysaccharide-induced apoptosis, suggesting that a constitutive or inducible cytoprotective protein(s) is required for endothelial survival. We have identified two known endothelial anti-apoptotic proteins, c-FLIP and Mcl-1, the expression of which is decreased markedly in the presence of cycloheximide. Decreased expression of both proteins preceded apoptosis evoked by lipopolysaccharide + cycloheximide. Caspase inhibition protected against apoptosis, but not the decreased expression of c-FLIP and Mcl-1, suggesting that they exert protection upstream of caspase activation. Inhibition of the degradation of these two proteins with the proteasome inhibitor, lactacystin, prevented lipopolysaccharide + cycloheximide-induced apoptosis. Similarly, lactacystin protected against endothelial apoptosis induced by either tumor necrosis factor-alpha or interleukin-1beta in the presence of cycloheximide. That apoptosis could be blocked in the absence of new protein synthesis by inhibition of the proteasome degradative pathway implicates the requisite involvement of a constitutively expressed protein(s) in the endothelial cytoprotective pathway. Finally, reduction of FLIP expression with antisense oligonucleotides sensitized endothelial cells to LPS killing, demonstrating a definitive role for FLIP in the protection of endothelial cells from LPS-induced apoptosis.
Databáze: OpenAIRE